Ocular Melanoma

These analyses revealed that AMF directly targets smoothened (SMO) to disrupt the SHh signaling pathway, thereby suppressing RB stem cell (RBSC) self-renewal and tumor progression. This work uncovers a previously unreported mechanism by which AMF hinders RB development and highlights its potential as a promising therapeutic candidate for this aggressive pediatric cancer.

This case illustrates a rare late local recurrence of choroidal melanoma with different appearance from the original tumor. It also highlights the diagnostic and prognostic role of transretinal biopsy in confirming the nature of the lesion as a recurrence and the option of proton beam radiation as salvage therapy.

Serum levels of CEA and CA19-9 normalized one month postoperatively, and no recurrence has been observed during follow-up. When a multilocular cystic mass with cyst-in-cyst morphology and a stained glass-like appearance is identified in the liver-even in the absence of definite malignant imaging features-MCN should be considered, including in cases arising in the right hepatic lobe.

Understanding the underlying mechanisms involved in RB and exploring new treatment strategies is a crucial step toward developing more effective and less invasive therapeutic approaches that can improve patient outcomes. This review summarizes the significant genetic and epigenetic alterations involved in RB tumorigenesis, current therapeutic strategies, and future treatment prospects for patients with RB.

P=N/A, N=32, Terminated, Centre Antoine Lacassagne | Phase classification: P2 --> P=N/A

Analogous PAX3 positive populations were also identified in mouse and human single-cell transcriptomic datasets. Collectively, these findings establish a critical role for Mitfa-independent melanocyte progenitors in UM pathogenesis.

A high frequency of NA and the Klippel-Trénaunay phenotype (or leg-length discrepancy) was observed in phacomatosis melanocesioflammea. The existence of "pseudodidymosis cesioanemica" is also corroborated.

IL-8 may be involved in CM-related inflammatory microenvironments and secondary exudative retinal detachment. It is a potential biomarker and provides a new target for targeted anti-inflammatory therapy and improved patient prognosis.

P=N/A, N=63, Active, not recruiting, Aura Biosciences | Recruiting --> Active, not recruiting | N=500 --> 63 | Trial primary completion date: Dec 2029 --> Dec 2028

In conclusion, Hsa-let-7c-3p suppressed Rb cell proliferation/invasion and induced pyroptosis by negatively regulating ARHGAP11A. They are potential biomarkers of Rb.

MYCN promotes ferroptosis in RB via xCT and transsulfuration pathways. Targeting the MYCN-xCT-transsulfuration axis may offer a novel therapeutic approach for MYCN-amplified RB.